Leon Gerald Leanse

Dr. Leon Gerald Leanse

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 June 2020 in JCI Insight
Verified
Journal Article
Closed access
PDF file
LLLeon Gerald Leanse
Leon Gerald Leanse
XGXueping Sharon Goh
Xueping Sharon Goh
JCJi-Xin Cheng
Ji-Xin Cheng
DHDavid C. Hooper
David C. Hooper
Tianhong DaiTianhong Dai
Tianhong Dai
With the effectiveness of antimicrobials declining as antimicrobial resistance continues to threaten public health, we must look to alternative strategies for the treatment of infections. In this study, we investigated an innovative, drug-free, dual-wavelength irradiation approach that combines 2 wavelengths of light, 460 nm and 405 nm, against methicillin-resistant Staphylococcus aureus (MRSA). MRSA was initially irradiated with 460-nm light (90–360 J/cm 2 ) and subsequently irradiated with aliquots of 405-nm light (54–324 J/cm 2 ). For in vivo studies, mouse skin was abraded and infected with approximately 10 7 CFUs of MRSA and incubated for 3 hours before irradiating with 460 nm (360 J/cm 2 ) and 405 nm (342 J/cm 2 ). Naive mouse skin was also irradiated to investigate apoptosis. We found that staphyloxanthin, the carotenoid pigment in MRSA cells, promoted resistance to the antimicrobial effects of 405-nm light. In addition, we found that the photolytic effect of 460-nm light on staphyloxanthin attenuated resistance of MRSA to 405-nm light killing. Irradiation of 460 nm alone did not elicit any antimicrobial effect on MRSA. In a proof-of-principle mouse skin abrasion infection model, we observed significant killing of MRSA using the dual-wavelength irradiation approach. However, when either wavelength of light was administered alone, no significant decrease in bacterial viability was observed. Moreover, exposure of the dual-wavelength irradiation to naive mouse skin did not result in any visible apoptosis. In conclusion, a dual-wavelength irradiation strategy may offer an innovative, effective, and safe approach for the treatment of skin infections caused by MRSA.

12 September 2023 in Antibiotics
Verified
Journal Article
Open access
PDF file
LLLeon Gerald Leanse
Leon Gerald Leanse
SMSanjay Marasini
Sanjay Marasini
CACarolina Dos Anjos
Carolina Dos Anjos
Tianhong DaiTianhong Dai
Tianhong Dai
In recent years, with the increases in microorganisms that express a multitude of antimicrobial resistance (AMR) mechanisms, the threat of antimicrobial resistance in the global population has reached critical levels. The introduction of the COVID-19 pandemic has further contributed to the influx of infections caused by multidrug-resistant organisms (MDROs), which has placed significant pressure on healthcare systems. For over a century, the potential for light-based approaches targeted at combatting both cancer and infectious diseases has been proposed. They offer effective killing of microbial pathogens, regardless of AMR status, and have not typically been associated with high propensities of resistance development. To that end, the goal of this review is to describe the different mechanisms that drive AMR, including intrinsic, phenotypic, and acquired resistance mechanisms. Additionally, the different light-based approaches, including antimicrobial photodynamic therapy (aPDT), antimicrobial blue light (aBL), and ultraviolet (UV) light, will be discussed as potential alternatives or adjunct therapies with conventional antimicrobials. Lastly, we will evaluate the feasibility and requirements associated with integration of light-based approaches into the clinical pipeline.

19 November 2019 in Lasers in Surgery and Medicine
Verified
Journal Article
Closed access
PDF file
LLLeon Gerald Leanse
Leon Gerald Leanse
XGXueping Sharon Goh
Xueping Sharon Goh
Tianhong DaiTianhong Dai
Tianhong Dai

12 December 2021 in Photodiagnosis and Photodynamic Therapy
Verified
Journal Article
Closed access
JBJoão Felipe Besegato
João Felipe Besegato
Priscila Borges Gobbo de MeloPriscila Borges Gobbo de Melo
Priscila Borges Gobbo de Melo
PTPatrícia Eriko Tamae
Patrícia Eriko Tamae
AAAna Paula Aparecida Raimundo Alves
Ana Paula Aparecida Raimundo Alves
LRLuis Felipe Rondón
Luis Felipe Rondón
ARAlessandra Nara de Souza Rastelli
Alessandra Nara de Souza Rastelli

9 November 2023 in Advanced Science
Verified
Journal Article
Open access
LLLeon Gerald Leanse
Leon Gerald Leanse
CACarolina dos Anjos
Carolina dos Anjos
KKKylie Ryan Kaler
Kylie Ryan Kaler
JHJie Hui
Jie Hui
JBJeffrey M. Boyd
Jeffrey M. Boyd
Tianhong DaiTianhong Dai
Tianhong Dai
In the age of antimicrobial resistance, the urgency by which novel therapeutic approaches need to be introduced into the clinical pipeline has reached critical levels. Antimicrobial blue light (aBL), as an alternative approach, has demonstrated promise as a stand‐alone therapeutic method, albeit with a limited window of antimicrobial activity. Work by others indicates that treatment with antibiotics increases the production of reactive oxygen species (ROS) which may, in part, contribute to the bactericidal effects of antibiotics. These findings suggest that there may be potential for synergistic interactions with aBL, that similarly generates ROS. Therefore, in this study, the mechanism of aBL is investigated, and the potential for aBL to synergistically promote antibiotic activity is similarly evaluated. Furthermore, the translatability of using aBL and chloramphenicol in combination within a mouse model of Acinetobacter baumanii burn infection is assessed. It is concluded that porphyrins and hydroxyl radicals driven by “free iron” are paramount to the effectiveness of aBL; and aBL is effective at promoting multiple antibiotics in different multidrug‐resistant bacteria. Moreover, rROS up‐regulation, and promoted antibiotic uptake are observed during aBL+antibiotic exposure. Lastly, aBL combined with chloramphenicol appears to be both effective and safe for the treatment of A. baumannii burn infection. In conclusion, aBL may be a useful adjunct therapy to antibiotics to potentiate their action.

18 August 2023 in Antibiotics
Verified
Journal Article
Open access
PDF file
SMSanjay Marasini
Sanjay Marasini
Jennifer P CraigJennifer P Craig
Jennifer P Craig
SDSimon J Dean
Simon J Dean
LLLeon Gerald Leanse
Leon Gerald Leanse
There have been multiple reports of eye infections caused by antibiotic-resistant bacteria, with increasing evidence of ineffective treatment outcomes from existing therapies. With respect to corneal infections, the most commonly used antibiotics (fluoroquinolones, aminoglycosides, and cephalosporines) are demonstrating reduced efficacy against bacterial keratitis isolates. While traditional methods are losing efficacy, several novel technologies are under investigation, including light-based anti-infective technology with or without chemical substrates, phage therapy, and probiotics. Many of these methods show non-selective antimicrobial activity with potential development as broad-spectrum antimicrobial agents. Multiple preclinical studies and a limited number of clinical case studies have confirmed the efficacy of some of these novel methods. However, given the rapid evolution of corneal infections, their treatment requires rapid institution to limit the impact on vision and prevent complications such as scarring and corneal perforation. Given their rapid effects on microbial viability, light-based technologies seem particularly promising in this regard.